NCT02969525 A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis Status COMPLETED Phase PHASE2
NCT02925338 National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life Status COMPLETED Phase N/A
NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis Status COMPLETED Phase N/A
NCT02917434 Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis Status COMPLETED Phase NA
NCT02854163 Effect of Secukinumab in the Treatment of Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT02841176 Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis Status TERMINATED Phase NA
NCT02814175 A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL) Status COMPLETED Phase PHASE4
NCT02798211 Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo Status COMPLETED Phase PHASE4
NCT02771210 Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site Status COMPLETED Phase PHASE3
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) Status COMPLETED Phase N/A
NCT02745080 Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02662985 Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE3
NCT02627768 A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis Status COMPLETED Phase N/A
NCT02605642 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade Status COMPLETED Phase N/A
NCT02598739 Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis Status COMPLETED Phase NA
NCT02584855 A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02572700 Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis Status UNKNOWN Phase N/A